Skip to main content

Research in the Department of Medicine

The Department of Medicine excels at all stages of the research pipeline from basic discovery, clinical research, and trials, through implementation science and population health. Investments in our investigators and research infrastructure have fueled exponential increases in our department’s research portfolio.

Total award costs for 2023-24 fiscal year were $141.2 million, including $61.7 million in NIH funding. According to rankings released by the Blue Ridge Institute for Medical Research in 2023, the department ranked 30th in NIH funding among all departments of internal medicine at public medical schools in the United States.

Research productivity in the department continue to be exceptional.

The department is responsible for about a third of IU School of Medicine’s total publications and roughly 40% of the school’s high-impact publications. The department produced 1,093 of IU School of Medicine’s 3,439 total publications in 2023. That included 274 of 699 high-impact publications. This rapid growth in research productivity is a testament to the excellence work by investigators in the Department of Medicine and the department's collaborative spirit.

The department’s developed a five-year research strategic plan in 2023. Highlights include:

  • Increased scientific productivity from the Department of Medicine
  • Increased multidisciplinary research in the emerging high impact areas of Population Health, Precision Health and Health Equity
  • Increased patient access to potentially high impact clinical trials
  • Increased policy impact of departmental research output at system, state, national and global levels
  • Increased basic science discovery addressing the fundamental mechanisms of health and disease

Vice Chair for Research
5180-Fowler, Nicole

Nicole R. Fowler, PhD

Associate Professor of Medicine

Read Bio

Director, Medicine Research Administration
Becky Reynolds

Becky Reynolds

Lab Spotlight:

Michael Econs, MD, is Distinguished Professor of Medicine and Medical and Molecular Genetics and is the director of the division of Endocrinology and Metabolism at IU School of Medicine. With the support of the Scottish Rite of Indianapolis Foundation, the Econs Lab studies metabolic bone disease. Work in the Econs lab led to the discovery of FGF23, which eventually led to the first new therapy in over 30 years for X-linked hypophosphatemic rickets (XLH) and tumor-induced osteomalacia (burosumab, Crysvita®). In this video, you'll meet Econs Lab's team and learn about their research.

 

  

Learn about our research centers and institutes

Learn about our faculty labs

Department of Medicine Research Funding Sites

The Department of Medicine is proud to receive research funding from a variety of sources. 

Research Administration

The ORA provides exceptional support for IU's research community in order to catalyze research productivity.

Institutional Review Boards

IRBs were established to protect the rights and welfare of human subjects by reviewing research with safety in mind.

Internal Resources

The department has resources available for its scientists, including SOPs and grant examples.

Service Cores

Research at IU School of Medicine is supported by designated institutional cores and shared resources. These facilities offer cutting edge scientific services, enabling access to high-end equipment, advanced technologies and specialized expertise for all school investigators.

Core facilities are a pivotal part of the university’s research infrastructure, providing resources that allow groundbreaking science to happen. Core Facilities Administration provides financial support, administrative oversight, professional development, assessment, and communication of shared research resources to advance the research mission of IU School of Medicine

Service Cores

Research Updates

Get the latest news on Indiana University and IU School of Medicine researchers.